Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 303 of the 305 references it cites were found in a registry or an index.

European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)

Open access
Gorenek, Bulent, Boriani, Giuseppe, Dan, Gheorge-Andrei, Fauchier, Laurent, Fenelon, Guilherme, Huang, He, Kudaiberdieva, Gulmira, Lip, Gregory Y H, Mahajan, Rajiv, Potpara, Tatjana, Ramirez, Juan David, Vos, Marc A, Marin, Francisco, ESC Scientific Document Group, Blomstrom-Lundqvist, Carina, Rinaldi, Aldo, Bongiorni, Maria Grazia, Sciaraffia, Elena, Nielsen, Jens Cosedis, Lewalter, Thorsten, Zhang, Shu, Gutiérrez, Oswaldo, Fuenmayor, Abdel · 2018 · EP Europace

Abstract

Endocrine disorders are associated with various tachyarrhythmias, including atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), and bradyarrhythmias. Along with underlying arrhythmia substrate, electrolyte disturbances, glucose, and hormone levels, accompanying endocrine disorders contribute to development of arrhythmia. Arrhythmias may be life-threatening, facilitate cardiogenic shock development and increase mortality. The knowledge on the incidence of tachy- and bradyarrhythmias, clinical and prognostic significance as well as their management is limited; it is represented in observational studies and mostly in case reports on management of challenging cases. It should be also emphasized, that the topic is not covered in detail in current guidelines. Therefore, cardiologists and multidisciplinary teams participating in care of such patients do need the evidence-based, or in case of limited evidence expert-opinion based recommendations, how to treat arrhythmias using contemporary approaches, prevent their complications and recurrence in patients with endocrine disorders. In recognizing this close relationship between endocrine disorders and arrhythmias, the European Heart Rhythm Association (EHRA) convened a Task Force, with representation from Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE), with the remit of comprehensively reviewing the available evidence and publishing a joint consensus document on endocrine disorders and cardiac arrhythmias, and providing up-to-date consensus recommendations for use in clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1093/europace/euy051

Cites

303 of 303 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 305 references

Research works printed but not linked: 1

  1. Cracana, 2016, Severe amiodarone-induced bradycardia conceals sick sinus syndrome: case report, Rev Med Chir Soc Med Nat Iasi, 120, 110

Cited by

See all 46

Metadata

Authors
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., Ramirez, J. D., Vos, M. A., Marin, F., ESC Scientific Document Group, Blomstrom-Lundqvist, C., Rinaldi, A., Bongiorni, M. G., Sciaraffia, E., Nielsen, J. C., Lewalter, T., Zhang, S., Gutiérrez, O., & Fuenmayor, A.
Affiliations
  • Eskisehir Osmangazi University, Eskisehir, Turkey
  • University of Modena and Reggio Emilia (IT)
  • Carol Davila University of Medicine and Pharmacy (RO)
  • Université de Tours (FR)
  • Hospital Israelita Albert Einstein (BR)
  • Renmin Hospital of Wuhan University (CN)
  • Adana, Turkey
  • University of Birmingham (GB)
  • Royal Adelaide Hospital (AU)
  • University of Belgrade (RS)
  • Clinica CardioVid, Medellín, Antioquia, Colombia
  • University Medical Center Utrecht (NL)
  • HU Virgen de la Arrixaca, Murcia, Spain
  • Uppsala University (SE)
  • Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden
  • St Thomas’ Hospital, London, UK
  • Uppsala University Hospital (SE)
  • Aarhus University Hospital (DK)
  • Fu Wai Hospital (CN)
  • Hospital Clinica Bblica, San Jose, Costa Rica
  • Universidad de Los Andes (VE)
Venue
EP Europace
Published
2018-03-16
Volume
20
Issue
6
Pages
895-896
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2792402543
Cited by
43
References
305
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 2
FWCI
2.84
Type
journal article
Language
en
Open access
Locations
  • EP Europace (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
  • VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
Funders
Novo Nordisk Fonden (NNF16OC0018658)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
endocrine disorders, cardiac arrhythmias, tachyarrhythmias, bradycardia, atrial fibrillation, ventricular tachycardia, ventricular fibrillation, cardiac device therapy, antiarrhythmic therapy, electrolyte imbalance, consensus recommendations
MeSH terms
Arrhythmias, Cardiac, Endocrine System Diseases, Humans, Patient Care Management, Prognosis, Global Health, Comorbidity, Risk Assessment, Evidence-Based Medicine, Stroke, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). https://app.cochat.ai/papers/10.1093/europace/euy051
The paper
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., Ramirez, J. D., Vos, M. A., Marin, F., ESC Scientific Document Group, Blomstrom-Lundqvist, C., Rinaldi, A., Bongiorni, M. G., Sciaraffia, E., Nielsen, J. C., . . . Fuenmayor, A. (2018). European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). EP Europace. https://doi.org/10.1093/europace/euy051

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.